ACCOUNTS - Final Accounts preparation

Registered number: 02339750

Charity number: 801382

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

CONTENTS

	Page
Reference and administrative details of the company, its Trustees and advisers	1
Trustees' report	2 - 7
Independent examiner's report	8
Statement of financial activities	9
Balance sheet	10
Statement of cash flows	11
Notes to the financial statements	12 - 29

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS

FOR THE YEAR ENDED 31 DECEMBER 2024

Trustees	Mr J Limmer, Chair
	Mrs J Tompkins
	Mr D J Bailey (resigned 31 March 2024)
	Mrs I Neitsch
	Mr A Cleur
	Mr P Connolly
	Mr I Padda (resigned 30 April 2024)
	Ms L Ellis (resigned 30 April 2024)
	Ms P Kersten (appointed 30 April 2024, resigned 16 May 2025)
	Mr R Mason (appointed 30 April 2024)
	Mrs A Foot (appointed 30 September 2024)
	Mr J Tonkin (appointed 30 September 2024)

Company registered number

02339750

Charity registered number

801382

Registered office

Bradbury House

Merton Lane (North)

Canterbury

Kent

CT4 7DZ

Company secretary

Mr J Limmer

Chief executive officer

Ms H Coleman

Accountants

Magee Gammon

Chartered Accountants

Henwood House

Henwood

Ashford

Kent

TN24 8DH

Page 1

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

TRUSTEES' REPORT

FOR THE YEAR ENDED 31 DECEMBER 2024

The Trustees present their annual report together with the financial statements of the company for the 1 January 2024 to 31 December 2024. The Annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Since the company qualifies as small under section 382 of the Companies Act 2006, the Strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.

Objectives and activities

a. Policies and objectives

The charity is governed by its Memorandum and Articles of Association and aims to promote the relief of persons in the county of Kent who live with Multiple Sclerosis (MS) and other neurological conditions by any lawful means and in particular and without prejudice to the generality of the foregoing:

∙to provide advice, guidance and moral and practical support for persons living with MS

∙to provide therapy (including oxygen therapy) for persons living with MS or other similar symptoms or conditions

In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.

b. Activities for achieving objectives

To ensure the charitable company's aims are met, the charitable company has a general policy to bring together persons living with MS and persons interested or more widely affected by MS.
The charitable company administers and equips a centre for the provision of therapies. "Active" members are required to pay for membership to the centre, thereafter full members are asked for a donation contributing to the operating costs/cost of therapy and associate members are required to pay a fixed charge albeit one well below the market rate. The centre also raises funds through events and donations.
The major source of funds comes from the enormous support that the charity receives from Trusts and Foundations without whom the centre would not exist.
There have been no material changes in these policies since the last report.

Page 2

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

Achievements and performance

a. Review of activities

The charitable company has continued its main objective of providing a range of therapies, support and advice to those with MS, their families and carers.
2024 was the tenth year of operation in the New Centre which continues to provide a state of the art facility to its users and consequently the principal therapies of Physiotherapy & Hydrotherapy, Reflexology, Acupuncture and High Dose Oxygen Therapy have all remained in strong demand.
The Centre also continues to treat a range of non-MS conditions with High Dose Oxygen Therapy including some life long conditions such as fibromyalgia, cancer, post-operative wounds and sports injuries, the income from which assists in the subsidising of its services to members with MS.
Continual investment in Centre staff has further strengthened the offering available to Centre users. We additionally have recruited four new Trustees to fill skill vacancies.
As at the end of 2024 the Charity served 412 MS members and 313 Associate members (a total of 725 members).
The Trustees wish to record their grateful thanks to our volunteers and others who willingly donate their time and services to our cause. Their wonderful support ensures that the New Centre continues to provide care and support to members and will continue to do so for the foreseeable future.
The Trustees would like the extend a specific thank you to the Frank Brake Charitable Trust, the William Brake Charitable Trust, the James Tudor Foundation, the February Foundation, the Childwick Trust, Garfield Weston Foundation, the Lawson Trust, the Thomas J Horne Memorial Trust, Kent Community Foundation, Meads Trust, The Loveday Charitable Trust and the Edward Gostling Foundation.

b. Public awareness

The Trustees and the Executive Team continue to promote awareness of the Centre within the local community.

c. Public benefit

The Trustees have complied with their duty to have regard to the guidance on public benefit published by the Charity Commission in exercising their powers or duties.
The activities of the charity are directed to. providing significant support for those with MS and other similar conditions both through treatment and therapy, informal advice and peer support.
Any contribution made towards the running costs of the charity is at the discretion of the member with MS and all MS Members have the opportunity to benefit from the activities of the charity without charge. The balance of the running cost is subsidised through its fundraising and income generation activities.

Page 3

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

Achievements and performance (continued)

d. Achievements and performance overview

Kent MS Therapy Centre continues to extend the scope of therapies on offer. In 2024, the charity delivered a total of 12,257 sessions of therapy. A summary is shown below.

Therapy Data	Total Attendances	Total Distinct Attendees	Distinct MS Attendees	Distinct Associate Attendees
Acupuncture	167	20	9	9
Ai Chi	10	5	2	3
APS	170	12	9	2
Aqua Yoga	604	53	31	19
Balance Warrior	13	5	5	-
Boxfit	106	19	12	5
Counselling	221	34	23	7
Fit Pump	12	4	3	1
Gym Session	1,378	96	67	26
HIIT	33	10	6	4
Hydro Induction	17	17	5	12
Hydrotherapy	1,272	119	65	52
Leisure Swim	171	33	16	15
Massage / Reflexology	1,934	182	111	51
Melody Singers	156	11	8	2
Oxygen Therapy	4,589	251	109	131
Physio Assessment	142	140	86	49
Physio Treatment	372	81	56	23
Pilates	239	31	20	10
Podiatry	190	58	39	12
Stretch N Flex	35	12	8	3
Yoga	426	52	39	10
Total 2024	12,257	551*	259*	292*
Total 2023	13,005	585*	248*	337*

* This is the total distinct members over all therapies. A member may have accessed multiple therapies but that person will only be counted oncen int eh total distinct count. Therefore the sum of the distinct attendees will not equal the distinct total.

As we attract more Members with MS and extend our therapy offering the level of subsidy required to support our therapies increases. Fundraising and sustainable income generation becomes ever more important.

e. Fundraising and income generation

	Endowment Funds	Restricted Funds	Unrestricted Funds	Total Funds	Total Funds
	2024	2024	2024	2024	2023
Donations and legacies	175,000	76,773	449,517	701,290	571,132
Charitable activities	-	-	31,576	31,576	144,312
Other trading activities	-	-	118,785	118,785	114,353
Investments	1,196	-	1,980	3,176	1,487
Other income	-	-	3,004	3,004	179
Total income	£176,196	£76,773	£604,862	£857,831	£831,463

Financial review

Page 4

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

a. Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.

b. Reserves policy

The charitable company has maintained a tight control on expenditure throughout the year. It seeks to maintain a reserve account which is equivalent to 3 months running costs, whilst recognising that after a challenging year, it will take time to build reserves to this level.
General review
Incoming resources for the year amounted to £857,831 (2023 - £831,463) with expenditure totalling £764,029 (2023 - £756,958) resulting in a surplus of £93,802 (2023 - surplus of £74,505).

It is the Trustees intention to apply all funds received in any one year whilst maintaining an appropriate level of unrestricted reserves in accordance with the policy.
The charity is also grateful to its staff, therapists and volunteers who have assisted with income-generating activities.
Restricted funds for specific projects have been received during the year from the following sources:

Restricted funds received in 2024	Amount	Purpose
R G Hills Charitable Trust	£2,000	Physio- and hydrotherapy
MS Awareness Week Individual Donations	£1,734	Physio- and hydrotherapy
The Big Give 2023 Champion Funder	£1,875	Physio- and hydrotherapy
H R Pratt Boorman Family Foundation	£1,000	Physio- and hydrotherapy
Souter Charitable Trust	£2,000	Physio- and hydrotherapy
William Brake Foundation	£15,000	Physio- and hydrotherapy
Sir Jules Thorn Charitable Trust	£3,000	Physio- and hydrotherapy
Garfield Weston Foundation	£15,000	Physio- and hydrotherapy
F B Coales No.4 (Family) Trust	£3,000	Physio- and hydrotherapy
The Big Give 2024 Individual Donations	£10,000	Physio- and hydrotherapy
The February Foundation	£5,000	Physio- and hydrotherapy
The Lawson Trust	£5,000	Physio- and hydrotherapy
Auction Income from the Christmas Ball	£1,300	Physio- and hydrotherapy
Charlotte Marshall Charitable Trust	£452	Complementary therapies
Social Enterprise Kent	£4,905	Counselling (Mental Health Support Programme)
Kent Community Foundation	£9,000	Other - Capacity Building
Alf and Della Fasham	£300	Other - Water Heater
Pocock's Solicitors	£335	Other - Water Heater
Walker Construction Trust	£350	Other - Washing Machine
Hilary Brian	£128	Other - 2 SumUp Machines
Greg Mayne	£300	Other - Window Cleaning

Page 5

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

Structure, governance and management

a. Constitution

The company is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association on 5 March 1993. The company is a registered charity, number 801382.
The principal object of the company is the provision of services and support to aid and improve the condition of those living with Multiple Sclerosis.

b. Methods of appointment or election of Trustees

Trustees are appointed or reappointed at the Company Annual General Meeting and, under the Articles of Association, hold office for a term of three years and are eligible for re-election for a maximum of three terms with the option to extend this in special circumstances.

c. Organisational structure and decision-making policies

The board of trustees is responsible for governance of the charity and generally meets every month. The board sets the strategic direction and policy for the charity, agrees an annual budget, and monitors performance against it. The day-to-day management of the Centre is the responsibility of the Executive team.

d. Risk management

The Trustees have assessed the major risks to which the company is exposed, those related to the operations and finances of the company and are satisfied that systems and procedures are in place to mitigate exposure to the major risks.
The support we have had from our donors and sponsors has been unparalleled and very much appreciated; the centre remains in reasonable financial health considering the challenges imposed on fund raising.
We remain confident as Trustees that the centre will continue to improve and grow to better support the lives of people living with MS in Kent.

Future developments

Kent MS Therapy Centre continues to work to make more people with MS in Kent aware of the Centre and understand how it can help. Activities towards this aim include collaboration with existing MS support groups such as the MS Society, MS Trust, profile raising amongst NHS specialised groups and clinicians and more effective use of social media, along with continued relationships with mainstream media.
Our strategy to 2025 is built on three pillars:
1. Improve our financial sustainability by maximising the income from the Centre's building, alongside a new fundraising strategy focusing on multi-year donations.
2. Deliver support for more people with MS (and other conditions) across Kent by delivering therapies from other locations, in addition to the Centre in Canterbury.
3. Become recognised as a Centre of Excellence: providing leadership in the provision of care and being recognised as an organisation that continues to learn by seeking out knowledge and expertise in the wider community.
The executive team have made progress on all 3 pillars of our strategy during 2024. We are delighted with the collaboration with Christchurch University.

Page 6

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

Our Mission

"Improving the lives of those living with MS in Kent"
The Centre aims to radically improve the lives of those with Multiple Sclerosis, their families and those who care for them.
We aim to:
1. Provide a range of complementary therapies and specialist clinics,
2. Give advice, support and information to those living with MS, their carers and families, in an environment which encourages mutual support and friendship,
3. Be a Centre of Excellence which enables self-management of the condition,
4. Welcome people throughout Kent.

Statement of Trustees' responsibilities

The Trustees (who are also the directors of the company for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial . Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

∙select suitable accounting policies and then apply them consistently;

∙observe the methods and principles of the Charities SORP (FRS 102);

∙make judgements and accounting estimates that are reasonable and prudent;

∙state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;

∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the members of the board of Trustees on 18 September 2025 and signed on their behalf by:

___________________________

Mr J Limmer

(Chair of Trustees)

Page 7

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

INDEPENDENT EXAMINER'S REPORT

FOR THE YEAR ENDED 31 DECEMBER 2024

Independent examiner's report to the Trustees of Kent Multiple Sclerosis Therapy Centre Ltd ('the company')

I report to the charity Trustees on my examination of the accounts of the company for the year ended 31 December 2024.

Responsibilities and basis of report

As the Trustees of the company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the company's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

Since the company's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

1.	accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or
2.	the accounts do not accord with those records; or
3.	the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or
4.	the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

This report is made solely to the company's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the company's Trustees those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the company and the company's Trustees as a body, for my work or for this report.

Signed: Dated: 18 September 2025

Roland Parry FCA

Magee Gammon

Chartered Accountants

Page 8

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT)

FOR THE YEAR ENDED 31 DECEMBER 2024

	Endowment funds 2024	Restricted funds 2024	Unrestricted funds 2024	Total funds 2024	Total funds 2023
Note	£	£	£	£	£

Income and endowments from:
Donations and legacies	3	175,000	81,678	449,517	706,195	571,132
Charitable activities	4	-	-	31,576	31,576	144,312
Other trading activities	5	-	-	113,880	113,880	114,353
Investments	6	1,196	-	1,980	3,176	1,487
Other income	7	-	-	3,004	3,004	179
Total income and endowments		176,196	81,678	599,957	857,831	831,463

Expenditure on:
Raising funds	8	-	-	137,147	137,147	130,927
Charitable activities	9	-	106,811	520,071	626,882	626,031
Total expenditure		-	106,811	657,218	764,029	756,958

Net income/(expenditure)

176,196

(25,133)

(57,261)

93,802

74,505

Transfers between funds

(35,000)

35,000

Net movement in funds

141,196

9,867

(57,261)

93,802

74,505

Reconciliation of funds:
Total funds brought forward	-	22,804	1,544,135	1,566,939	1,492,434
Net movement in funds	141,196	9,867	(57,261)	93,802	74,505
Total funds carried forward	141,196	32,671	1,486,874	1,660,741	1,566,939

The Statement of financial activities includes all gains and losses recognised in the year.

The notes on pages 12 to 29 form part of these financial statements.

Page 9

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

REGISTERED NUMBER: 02339750

BALANCE SHEET

AS AT 31 DECEMBER 2024

			2024		2023
	Note		£		£

Fixed assets
Tangible assets	14		1,441,467		1,467,241
Current assets
Debtors	15	17,910		15,311
Cash at bank and in hand		272,597		163,732
		290,507		179,043
Creditors: amounts falling due within one year	16	(28,357)		(21,870)
Net current assets			262,150		157,173
Creditors: amounts falling due after more than one year	17		(42,876)		(57,475)
Total net assets			1,660,741		1,566,939

Charity funds
Endowment funds	19	141,196	-
Restricted funds	19	32,671	22,804
Unrestricted funds	19	1,486,874	1,544,135
Total funds		1,660,741	1,566,939

The company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees on 18 September 2025 and signed on their behalf by:

___________________________ Mr J Limmer (Chair of Trustees)
The notes on pages 12 to 29 form part of these financial statements.

Page 10

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2024

				2024	2023
				£	£

Cash flows from operating activities
Net cash used in operating activities	122,192	106,153
Cash flows from investing activities
Purchase of tangible fixed assets	-	(113,484)
Net cash provided by/(used in) investing activities	-	(113,484)

Cash flows from financing activities
Cash inflows from new borrowing	-	77,000
Repayments of borrowing	(13,327)	(9,279)
Net cash (used in)/provided by financing activities	(13,327)	67,721

Change in cash and cash equivalents in the year	108,865	60,390
Cash and cash equivalents at the beginning of the year	163,732	103,342
Cash and cash equivalents at the end of the year	272,597	163,732

The notes on pages 12 to 29 form part of these financial statements

Page 11

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

1.	General information

The Kent Multiple Sclerosis Therapy Centre Limited is a private company, limited by guarantee, incorporated in England and Wales. The company registration number is 02339750.
The registered office address is Bradbury House, Merton Lane (North), Canterbury, Kent, CT4 7DZ.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Kent Multiple Sclerosis Therapy Centre Ltd meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

2.2

Income

All income is recognised once the company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

The recognition of income from legacies is dependent on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the company has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the company, can be reliably measured.

Grants are included in the Statement of financial activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.

Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.

Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service.

Page 12

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


	2.3	Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the company's objectives, as well as any associated support costs.

All expenditure is inclusive of irrecoverable VAT.

2.4

Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the company; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

2.5

Tangible fixed assets and depreciation

Tangible fixed assets costing £NIL or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, as below.

Depreciation is provided on the following basis:

Buildings	-	2%	straight line basis
Plant and machinery	-	10%	straight line basis
Fixtures and fittings	-	20%	reducing balance basis
Computer equipment	-	33%	straight line basis

2.6

Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.7

Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

Page 13

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.8

Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost.

2.9

Financial instruments

The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

2.10

Operating leases

Rentals paid under operating leases are charged to the Statement of financial activities on a straight-line basis over the lease term.

2.11

Pensions

The company operates a defined contribution pension scheme and the pension charge represents the amounts payable by the company to the fund in respect of the year.

2.12

Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the company and which have not been designated for other purposes.

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the company for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 14

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

3.	Income from donations and legacies

		Endowment funds 2024	Restricted funds 2024	Unrestricted funds 2024	Total funds 2024	Total funds 2023
		£	£	£	£	£


Donations	175,000	14,096	105,704	294,800	62,051
Legacies	-	-	3,549	3,549	66,842
Grants	-	67,582	119,200	186,782	240,773
Treatment donations	-	-	221,064	221,064	201,466
	175,000	81,678	449,517	706,195	571,132
Total 2023	-	97,260	473,872	571,132

4.	Income from charitable activities

		Unrestricted funds 2024	Total funds 2024	Total funds 2023
		£	£	£


Membership subscriptions	20,835	20,835	25,675
Rental income	10,741	10,741	118,637
	31,576	31,576	144,312
Total 2023	144,312	144,312

Page 15

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

5.	Income from other trading activities
	Income from fundraising events

		Unrestricted funds 2024	Total funds 2024	Total funds 2023
		£	£	£


Fundraising events	67,041	67,041	67,999
Sale of goods and literature	46,839	46,839	46,354
	113,880	113,880	114,353
Total 2023	114,353	114,353

6.	Investment income

		Endowment funds 2024	Unrestricted funds 2024	Total funds 2024	Total funds 2023
		£	£	£	£


Bank interest receivable	1,196	-	1,196	-
Investment income	-	1,980	1,980	1,487
	1,196	1,980	3,176	1,487
Total 2023	-	1,487	1,487

7.	Other incoming resources

		Unrestricted funds 2024	Total funds 2024	Total funds 2023
		£	£	£


Income generated from solar panels	3,004	3,004	179
Total 2023	179	179

Page 16

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

Expenditure on raising funds

Fundraising expenses

	Unrestricted funds 2024	Total funds 2024	Total funds 2023
	£	£	£


Allocated centrally incurred fundraising and governance costs	137,147	137,147	130,927
Total 2023	130,927	130,927

9.	Analysis of expenditure on charitable activities
	Summary by fund type

		Restricted funds 2024	Unrestricted funds 2024	Total 2024	Total 2023
		£	£	£	£


Charitable activities	106,811	520,071	626,882	626,031
Total 2023	82,193	543,838	626,031

10.	Analysis of expenditure by activities

		Activities undertaken directly 2024	Support costs 2024	Total funds 2024	Total funds 2023
		£	£	£	£


Charitable activities	319,813	307,069	626,882	626,031
Total 2023	330,204	295,827	626,031

Page 17

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

10.Analysis of expenditure by activities (continued)

Analysis of direct costs

	Activities 2024	Total funds 2024	Total funds 2023
	£	£	£


Wages and salaries	117,141	117,141	108,341
Maintenance of equipment and buildings	34,584	34,584	19,000
Oxygen	24,847	24,847	25,138
Physiotherapy, reflexology and counselling	99,579	99,579	133,537
Training courses	3,896	3,896	1,587
Depreciation	37,498	37,498	40,321
Governance costs	2,268	2,268	2,280
	319,813	319,813	330,204
Total 2023	330,204	330,204

Page 18

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

10.Analysis of expenditure by activities (continued)

Analysis of support costs

	Activities 2024	Total funds 2024	Total funds 2023
	£	£	£


Wages and salaries	169,296	169,296	184,235
Travelling expenses	2,232	2,232	925
Cleaning and general costs	35,079	35,079	24,460
Printing, postage, stationery and copies	1,950	1,950	2,195
Advertising and recruitment	857	857	2,385
Telephone	7,043	7,043	7,413
Insurance	9,206	9,206	6,877
Rent and rates	5,125	5,125	1,000
Light and heat	19,913	19,913	30,219
Licences and subscriptions	22,312	22,312	10,654
Bank charges	3,837	3,837	3,272
Computer and website expenses	19,671	19,671	12,456
Sundry expenses	962	962	1,070
Loan charges and interest	5,923	5,923	6,506
Professional fees	3,663	3,663	2,160
	307,069	307,069	295,827
Total 2023	295,827	295,827

.	Analysis of fundraising costs
		2024	2023
		£	£


Wages and salaries	99,348	97,282
Fundraising expenditure	35,894	30,502
Cost of goods sold	1,905	3,143
	137,147	130,927

Page 19

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

11.	Independent examiner's remuneration
		2024	2023
		£	£

Fees payable to the company's independent examiner for the independent examination of the company's annual accounts

2,268

2,280

12.	Staff costs
		2024	2023
		£	£


Wages and salaries	353,705	357,374
Social security costs	24,543	24,758
Contribution to defined contribution pension schemes	7,537	7,726
	385,785	389,858

The average number of persons employed by the company during the year was as follows:
	2024	2023
	No.	No.


	Employees	16	17

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:
	2024	2023
	No.	No.


	In the band £60,001 - £70,000	1	1

The key management personnel of the company comprise the Trustees and the Chief Executive. The total employee benefits of the key management personnel of the Charity was £63,750 (2023 - £62,132).

13.	Trustees' remuneration and expenses
	During the year, no Trustees received any remuneration or other benefits (2023 - £NIL).

During the year ended 31 December 2024, no Trustee expenses have been incurred (2023 - £NIL).

Page 20

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

14.	Tangible fixed assets

	Long-term leasehold property	Plant and machinery	Fixtures and fittings	Computer equipment	Total
	£	£	£	£	£
Cost or valuation
At 1 January 2024	1,684,438	146,462	75,973	52,406	1,959,279
Additions	-	11,724	-	-	11,724
At 31 December 2024	1,684,438	158,186	75,973	52,406	1,971,003
Depreciation
At 1 January 2024	258,727	121,937	60,246	51,128	492,038
Charge for the year	23,410	12,441	3,142	(1,495)	37,498
At 31 December 2024	282,137	134,378	63,388	49,633	529,536
Net book value
At 31 December 2024	1,402,301	23,808	12,585	2,773	1,441,467
At 31 December 2023	1,425,711	24,525	15,727	1,278	1,467,241

15.	Debtors
		2024	2023
		£	£


Due within one year
Trade debtors	4,351	4,765
Prepayments and accrued income	13,559	10,546
	17,910	15,311

Page 21

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024


16.	Creditors: Amounts falling due within one year
		2024	2023
		£	£


Other loans	14,598	13,326
Trade creditors	10,218	5,574
Other creditors	1,206	970
Accruals and deferred income	2,335	2,000
	28,357	21,870

17.	Creditors: Amounts falling due after more than one year
		2024	2023
		£	£


	Other loans	42,876	57,475

18.	Financial instruments
		2024	2023
		£	£

	Financial assets
	Financial assets measured at fair value through income and expenditure	272,597	163,732

Financial assets measured at fair value through income and expenditure comprise of cash at bank and in hand.

Page 22

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

19.

Statement of funds

Statement of funds - current year
	Balance at 1 January 2024 £	Income £	Expenditure £	Transfers in/out £	Balance at 31 December 2024 £
Unrestricted funds

	Designated funds
	Designated Funds	1,467,241	-	-	(25,774)	1,441,467

General funds
General Funds	76,894	599,957	(657,218)	25,774	45,407
Total Unrestricted funds	1,544,135	599,957	(657,218)	-	1,486,874

Endowment funds
Expendable endowment funds	-	175,000	-	(35,000)	140,000
Bank interest attributable	-	1,196	-	-	1,196
	-	176,196	-	(35,000)	141,196

Restricted funds
Complementary Therapies	-	452	(452)	-	-
Counselling	4,000	4,905	(6,475)	-	2,430
Other	2,229	10,413	(47,642)	35,000	-
Physiotherapy and Hydrotherapy	16,575	65,908	(52,242)	-	30,241
	22,804	81,678	(106,811)	35,000	32,671

Total of funds

1,566,939

857,831

(764,029)

1,660,741

Page 23

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

19.

Statement of funds (continued)

Physiotherapy and Hydrotherapy
The balance of funds donated last year by the Mike Butcher Donation of £10,555 was utilised during the year.
The balance of funds donated last year by The Big Give 2023 of £6,020 was utilised during the year.
R G Hills Charitable Trust donated £2,000. This was utilised during the year.
MS Awareness Week donations totalled £1,734. Of this, £1,400 was utilised during the year and £334 has been carried forward.
The Big Give Christmas Challenge 2023 Champion Funder donated £1,875. This was utilised during the year.
H R Pratt Boorman Family Foundation donated £1,000. This was utilised during the year.
Souter Charitable Trust donated £2,000. This was utilised during the year.
William Brake Foundation donated £15,000. This was utilised during the year.
Sir Jules Thorn Charitable Trust donated £3,000. This was utilised during the year.
Garfield Weston Foundation donated £15,000. Of this, £2,226 was utilised during the year and £12,774 has been carried forward.
F B Coales No.4 (Family) Trust donated £3,000. This was utilised during the year.
Big Give Christmas Challenge 2024 individual donations totalled £10,000. Of this, £2,870 was utilised during the year and £7,130 has been carried forward.
The February Foundation donated £5,000. This has been carried forward.
The Lawson Trust donated £5,000. This has been carried forward.
Auction income from the Christmas Ball 2024 totalled £1,300. Of this, £1,297 was utilised during the year and £3 has been carried forward.

Complementary Therapies
Charlotte Marshall Charitable Trust donated £452. This was utilised during the year.

Counselling
The balance of funds donated last year by Beerling Foundation of £1,250 was utilised during the year.
The balance of funds donated last year by Cantiacorum Foundation of £500 was utilised during the year.
The balance of funds donated last year by The Grace Trust of £1,000 was utilised during the year.
The balance of funds donated last year by The Sir James Roll Charitable Trust of £1,250 was utilised during the year.
Social Enterprise Kent donated £4,905. Of this, £2,475 was utilised during the year and £2,430 has been carried forward.

Page 24

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

19.

Statement of funds (continued)

Page 25

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

19.

Statement of funds (continued)

Statement of funds - prior year
	Balance at 1 January 2023 £	Income £	Expenditure £	Transfers in/out £	Balance at 31 December 2023 £
Unrestricted funds

	Designated funds
	Designated Funds	1,394,078	-	-	73,163	1,467,241

General funds
General Funds	63,186	734,203	(674,765)	(45,730)	76,894
Total Unrestricted funds	1,457,264	734,203	(674,765)	27,433	1,544,135

Restricted funds
Complementary Therapies	4,900	15,725	(20,625)	-	-
Counselling	1,718	8,000	(5,718)	-	4,000
Other	6,379	27,062	(7,150)	(24,062)	2,229
Oxygen Therapy	1,982	4,453	(6,435)	-	-
Physiotherapy and Hydrotherapy	20,191	42,020	(42,265)	(3,371)	16,575
	35,170	97,260	(82,193)	(27,433)	22,804

Total of funds

1,492,434

831,463

(756,958)

1,566,939

Page 26

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

20.

Summary of funds

		Summary of funds - current year
			Balance at 1 January 2024 £	Income £	Expenditure £	Transfers in/out £	Balance at 31 December 2024 £

Designated funds	1,467,241	-	-	(25,774)	1,441,467
General funds	76,894	599,957	(657,218)	25,774	45,407
Endowment funds	-	176,196	-	(35,000)	141,196
Restricted funds	22,804	81,678	(106,811)	35,000	32,671
	1,566,939	857,831	(764,029)	-	1,660,741

		Summary of funds - prior year
			Balance at 1 January 2023 £	Income £	Expenditure £	Transfers in/out £	Balance at 31 December 2023 £

Designated funds	1,394,078	-	-	73,163	1,467,241
General funds	63,186	734,203	(674,765)	(45,730)	76,894
Restricted funds	35,170	97,260	(82,193)	(27,433)	22,804
	1,492,434	831,463	(756,958)	-	1,566,939

21.

Analysis of net assets between funds

Analysis of net assets between funds - current period
	Endowment funds 2024	Restricted funds 2024	Unrestricted funds 2024	Total funds 2024
	£	£	£	£

Tangible fixed assets	-	-	1,441,467	1,441,467
Current assets	141,196	32,671	116,640	290,507
Creditors due within one year	-	-	(28,357)	(28,357)
Creditors due in more than one year	-	-	(42,876)	(42,876)
Total	141,196	32,671	1,486,874	1,660,741

Page 27

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

21.Analysis of net assets between funds (continued)

Analysis of net assets between funds - prior period
	Restricted funds 2023	Unrestricted funds 2023	Total funds 2023
	£	£	£

Tangible fixed assets	-	1,467,241	1,467,241
Current assets	22,804	156,239	179,043
Creditors due within one year	-	(21,870)	(21,870)
Creditors due in more than one year	-	(57,475)	(57,475)
Total	22,804	1,544,135	1,566,939

22.	Reconciliation of net movement in funds to net cash flow from operating activities
		2024	2023
		£	£

Net income for the period (as per Statement of Financial Activities)	93,802	74,505
Adjustments for:
Depreciation charges	37,498	40,321
Increase in debtors	(2,599)	(11,452)
Increase in creditors	5,215	2,779
Net cash provided by operating activities	133,916	106,153

23.	Analysis of cash and cash equivalents
		2024	2023
		£	£

	Cash in hand	272,597	163,732
	Total cash and cash equivalents	272,597	163,732

Page 28

KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

24.	Analysis of changes in net debt

		At 1 January 2024	Cash flows	At 31 December 2024
		£	£	£

Cash at bank and in hand	163,732	108,865	272,597
Debt due within 1 year	(13,326)	(1,272)	(14,598)
Debt due after 1 year	(57,475)	14,599	(42,876)
	92,931	122,192	215,123

25.	Pension commitments

The charity operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the charity in an independently administered fund. The pension cost charge represents contributions payable by the charity to the fund and amounted to £7,537 (2023 - £7,726). Contributions totalling £nil (2023 - £nil) were payable to the fund at the balance sheet date and are included in creditors.

26.	Operating lease commitments
	At 31 December 2024 the company had commitments to make future minimum lease payments under non-cancellable operating leases as follows:
		2024	2023
		£	£


Not later than 1 year	1,000	1,000
Later than 1 year and not later than 5 years	4,000	4,000
Later than 5 years	114,000	115,000
	119,000	120,000

27.	Members' liability

Each member of the charitable company undertakes to contribute to the assets of the company in the event of it being wound up while they are a member, or within one year after they cease to be a member, such amount as may be required, not exceeding £1 for the debts and liabilities contracted before they cease to be a member.

28.	Related party transactions
	The company has not entered into any related party transaction during the year, nor are there any outstanding balances owing between related parties and the company at 31 December 2024.

Page 29